Automate Your Wheel Strategy on STE
With Tiblio's Option Bot, you can configure your own wheel strategy including STE - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol STE
- Rev/Share 55.5546
- Book/Share 67.3202
- PB 3.3255
- Debt/Equity 0.0189
- CurrentRatio 1.9574
- ROIC 0.072
- MktCap 22022315770.0
- FreeCF/Share 7.9402
- PFCF 28.2224
- PE 35.794
- Debt/Assets 0.0123
- DivYield 0.0102
- ROE 0.0946
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 4
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | STE | Morgan Stanley | Equal Weight | Overweight | -- | $276 | July 15, 2025 |
| Initiation | STE | Jefferies | -- | Hold | -- | $263 | May 29, 2025 |
News
Steris (STE) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Steris (STE), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.
Read More
Will Healthcare Growth Help STE Beat on Q1 Earnings?
Published: August 01, 2025 by: Zacks Investment Research
Sentiment: Positive
STERIS is likely to have experienced a strong Q1 with 14.3% EPS growth as Healthcare and AST segments show solid momentum.
Read More
Steris (STE) Earnings Expected to Grow: Should You Buy?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Steris (STE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Steris (STE) Loses 6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Published: July 22, 2025 by: Zacks Investment Research
Sentiment: Negative
Steris (STE) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read More
Should You Continue to Hold STERIS Stock in Your Portfolio Now?
Published: July 10, 2025 by: Zacks Investment Research
Sentiment: Negative
STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.
Read More
Why Is Steris (STE) Down 1.8% Since Last Earnings Report?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Negative
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Read More
AST Business Growth & Strategic Acquisitions Support STERIS Stock
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
STE frequently engages in strategic acquisitions and joint ventures to optimize its portfolio of businesses.
Read More
Is it the Right Time to Hold STERIS Stock in Your Portfolio?
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
STE stays on investors' radars due to the strength of its Healthcare arm and strong rebound potential in the AST segment.
Read More
Deciphering Steris (STE) International Revenue Trends
Published: May 19, 2025 by: Zacks Investment Research
Sentiment: Neutral
Examine Steris' (STE) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
Read More
STERIS plc (STE) Q4 2025 Earnings Call Transcript
Published: May 15, 2025 by: Seeking Alpha
Sentiment: Neutral
STERIS plc (NYSE:STE ) Q4 2025 Results Conference Call May 15, 2025 9:00 AM ET Company Participants Julie Winter - Investor Relations Mike Tokich - Senior Vice President and Chief Financial Officer Dan Carestio - President and Chief Executive Officer Conference Call Participants Dave Turkaly - Citizens Mike Matson - Needham & Company Patrick Wood - Morgan Stanley Mac Etoch - Stephens, Inc Michael Polark - Wolfe Research Jason Bednar - Piper Sandler Brett Fishbin - KeyBanc Operator Good morning, everyone, and welcome to the STERIS plc Fourth Quarter 2025 Conference Call. All participants will be in a listen-only mode.
Read More
STE Q4 Earnings Beat, Margins Expand, Stock Up in Aftermarket
Published: May 15, 2025 by: Zacks Investment Research
Sentiment: Positive
STERIS' fourth-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues.
Read More
What Analyst Projections for Key Metrics Reveal About Steris (STE) Q4 Earnings
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Neutral
Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Read More
10 Undervalued Dividend Growth Stocks: May 2025
Published: May 07, 2025 by: Seeking Alpha
Sentiment: Positive
I rank a selection of undervalued dividend growth stocks in Dividend Radar and present the top ten stocks for consideration. I use two valuation screens, one based on my fair value estimate, and another comparing each stock's forward dividend yield with its 5-year average dividend yield. To rank stocks, I do a quality assessment and sort candidates by quality scores, breaking ties with additional metrics.
Read More
Will Applied Sterilization Growth Help STE Beat Q4 Earnings Estimates?
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
STERIS is expected to have experienced an increase in bioprocessing demand in the fourth quarter.
Read More
Steris (STE) Up 3% Since Last Earnings Report: Can It Continue?
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Steris (STE) reported earnings 30 days ago. What's next for the stock?
Read More
About STERIS plc (STE)
- IPO Date 1992-06-01
- Website https://www.steris.com
- Industry Medical - Devices
- CEO Daniel A. Carestio
- Employees 18000